Understanding Stroke Recovery with TMS
This study, called VERIFY, is looking at how well different tools can predict recovery after a stroke, especially for arm and hand movement. Researchers are using a diagnostic test called Transcranial Magnetic Stimulation (TMS) to measure motor evoked potential (MEP) within the first week of hospitalization. They are also looking at MRI scans and clinical information. The goal is to see if these tools can accurately predict how much arm and hand function you might regain 90 days after a stroke. This information will help doctors better understand and personalize treatments for stroke survivors. You may be able to join if you are 18 or older and have had a stroke that affects one side of your body, causing weakness in your arm or hand. The study aims to include 657 participants, but its current status is unclear.
- Study design
- This is an observational study, meaning researchers will collect information without giving any new treatments. It plans to include 657 participants.
- What's involved
- The TMS procedure will be conducted during the first week of hospitalization. Your arm and hand function will be measured 90 days after your stroke.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your arm and hand function will be measured 90 days after your stroke.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
At a glance
Conditions
Where it's being run
45 sites across 23 statesStudy leadership
- Pooja Khatri, MD · PRINCIPAL_INVESTIGATOR · Yale University
- Steve Cramer, MD · PRINCIPAL_INVESTIGATOR · University of California, Los Angeles
- Cathy Stinear, PhD · PRINCIPAL_INVESTIGATOR · University of Auckland, New Zealand
- Achala Vagal, MD · PRINCIPAL_INVESTIGATOR · University of Cincinnati
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Upper Extremity-Fugl Meyer (UE-FM) for AIM 190 days post-stroke
UE-FM score, as a continuous scale, adjusted for baseline score in analysis
- Action Research Arm Test (ARAT) for AIM 290 days post-stroke
ARAT categorized as 'excellent', 'good', 'limited', or 'poor'